These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3164562)

  • 1. Potentiation of fibroblast spreading by extracellular matrix from fibroblasts derived from phenytoin-induced gingival overgrowth.
    Modéer T; Dahllöf G; Otteskog P
    Acta Odontol Scand; 1988 Apr; 46(2):101-4. PubMed ID: 3164562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of phenytoin on cytoplasmic free Ca2+ level in human gingival fibroblasts.
    Modéer T; Brunius G; Mendez C; Juntti-Berggren L; Berggren PO
    Scand J Dent Res; 1991 Aug; 99(4):310-5. PubMed ID: 1771377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of phenytoin on intracellular 45Ca2+ accumulation in gingival fibroblasts in vitro.
    Brunius G; Modéer T
    J Oral Pathol Med; 1989 Sep; 18(8):485-9. PubMed ID: 2607469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of sulfated glycosaminoglycans by human gingival fibroblasts from phenytoin-induced gingival overgrowth in vitro.
    Dahllöf G; Hjerpe A
    Scand J Dent Res; 1987 Jun; 95(3):250-5. PubMed ID: 3474765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenytoin and 5-(p-hydroxyphenyl)-5-phenylhydantoin do not alter the effects of bacterial and amplified plaque extracts on cultures of fibroblasts from normal and overgrown gingivae.
    Smith QT; Hinrichs JE
    J Dent Res; 1987 Aug; 66(8):1393-8. PubMed ID: 3476609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenytoin and cyclosporin A suppress the expression of MMP-1, TIMP-1, and cathepsin L, but not cathepsin B in cultured gingival fibroblasts.
    Yamada H; Nishimura F; Naruishi K; Chou HH; Takashiba S; Albright GM; Nares S; Iacopino AM; Murayama Y
    J Periodontol; 2000 Jun; 71(6):955-60. PubMed ID: 10914799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative histopathologic assessment of developing phenytoin-induced gingival overgrowth in the cat.
    Hassell TM; Roebuck S; Page RC; Wray SH
    J Clin Periodontol; 1982 Sep; 9(5):365-72. PubMed ID: 6958684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrastructural quantitation of connective tissue changes in phenytoin-induced gingival overgrowth in the ferret.
    Hall BK; Squier CA
    J Dent Res; 1982 Jul; 61(7):942-52. PubMed ID: 6953128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced prostaglandin biosynthesis in human gingival fibroblasts isolated from patients treated with phenytoin.
    Modéer T; Andurén I; Lerner UH
    J Oral Pathol Med; 1992 Jul; 21(6):251-5. PubMed ID: 1501156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenytoin-induced gingival overgrowth in rats infected with Streptococcus sobrinus 6715.
    Morisaki I; Mihara J; Kato K; Kitamura K; Adachi C; Sobue S; Hamada S
    Arch Oral Biol; 1990; 35(9):753-8. PubMed ID: 2151111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of G₁ cell cycle arrest in human gingival fibroblasts exposed to phenytoin.
    Takeuchi R; Matsumoto H; Akimoto Y; Fujii A
    Fundam Clin Pharmacol; 2014 Feb; 28(1):114-9. PubMed ID: 22888954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenytoin-induced gingival overgrowth caused by death receptor pathway malfunction.
    Takeuchi R; Matsumoto H; Arikawa K; Taguchi C; Nakayama R; Nasu I; Hiratsuka K
    Oral Dis; 2017 Jul; 23(5):653-659. PubMed ID: 28160766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cyclosporine and phenytoin on biomarker expressions in gingival fibroblasts of children and adults: an in vitro study.
    Vahabi S; Salman BN; Rezazadeh F; Namdari M
    J Basic Clin Physiol Pharmacol; 2014 May; 25(2):167-73. PubMed ID: 23907422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Biochemical characterization of phenytoin-induced hyperplastic human gingival fibroblasts. Non-collagenous proteins biosynthesis].
    Deguchi S; Ooyama A; Fukuno M; Hori T; Kawase T; Aoki F; Suzuki K; Saito S
    Nihon Shishubyo Gakkai Kaishi; 1988 Dec; 30(4):1047-54. PubMed ID: 3270656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regression of phenytoin-induced gingival overgrowth after withdrawal of medication.
    Dahllöf G; Axiö E; Modéer T
    Swed Dent J; 1991; 15(3):139-43. PubMed ID: 1876981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myofibroblasts in phenytoin-induced hyperplastic connective tissue in the rat and in human gingival overgrowth.
    Dill RE; Iacopino AM
    J Periodontol; 1997 Apr; 68(4):375-80. PubMed ID: 9150043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histologic evidence for impaired growth control in diphenylhydantoin gingival overgrowth in man.
    Hassell TM; Page RC; Lindhe J
    Arch Oral Biol; 1978; 23(5):381-4. PubMed ID: 278576
    [No Abstract]   [Full Text] [Related]  

  • 18. The pathogenesis of drug-induced gingival overgrowth.
    Seymour RA; Thomason JM; Ellis JS
    J Clin Periodontol; 1996 Mar; 23(3 Pt 1):165-75. PubMed ID: 8707974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of a plaque control program on the development of phenytoin-induced gingival overgrowth. A 2-year longitudinal study.
    Dahllöf G; Modéer T
    J Clin Periodontol; 1986 Oct; 13(9):845-9. PubMed ID: 3465754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenytoin-induced gingival overgrowth control in severely retarded children.
    Steinberg SC; Steinberg AD
    J Periodontol; 1982 Jul; 53(7):429-33. PubMed ID: 6956708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.